-
-
[1]Bravo AA, Sheth SG, Chopra S.Liver biopsy[J].N Engl J Med, 2001, 344 (7) ∶495~500. [2]中华医学会.慢性乙型肝炎防治指南[J].中华传染病杂志, 2005, 23∶421-431. [3]Lol ASF, McMahon BJ.AASLD practice guideline:Chronic hepati-tis B[J].Hepatology, 2007, 39∶857-861. [4]Maria G.Liver biopsy sampling in chronic viral hepatitis[J].Semi-nars in Liver Disease, 2004, 24 (1) ∶89. [5]Marcelo K.Liver Biopsy[J].Am J Gastroenterol, 2004, 99 (8) ∶1416. [6]Pohl A, Behling C, Oliver D, et al.Serum aminotransferase levelsand platelet counts as predictors of degree of fibrosis in chronic hepa-titis C virus infection[J].Am J Gastroenterol, 2001, 96∶3142-3146. [7]陈永鹏, 冯筱榕, 戴琳, 等.代偿性肝硬化无创性诊断指标的筛选及评价[J].中华肝脏病杂志, 2003, 11∶225-227. [8]Castera L, Hartmann DJ, Chapel F, et al.Serum laminin and typeⅣcollagen are accurate markers of histologically severe alcoholichepatitis in patients with cirrhosis[J].J Hepatol, 2000, 32∶412-418. [9]Patel K, Gordon SC, Jacobson I, et al.Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients[J].J Hepatol, 2004, 41∶935-942. [10]Castera L, Vergniol J, Foucher J, et al.Prospective comparison oftransient elastography, Fibrotest, APRI, and liver biopsy for the as-sessment of fibrosis in chronic hepatitis C[J].Gastroenterology, 2005, 128∶343-350. [11]张文胜, 王宝恩, 王泰龄, 等.慢性乙型肝炎肝纤维化无创性诊断模型的建立[J].中华肝脏病杂志, 2006, 14 (3) ∶312-315. [12]Castera L, Forns X, Alberti A.Non-invasive evaluation of liverfibrosis using transient elastography[J].J Hepatol, 2008, 48 (5) ∶835-47. [13]Dienstag JL, Goldin RD, Heathcote EJ, et al.Histological outcomeduring long-term lamivudine therapy[J].Gastroenterology, 2003, 125 (4) ∶1286-1287. [14]Crockett SD, Kaltenbach T, Keeffe EB.Do we still need a liver bi-opsy?Are the serum fibrosis tests ready for prime time?[J].ClinLiver Dis, 2006, 10 (3) ∶513-534.
本文二维码
计量
- 文章访问数: 3333
- HTML全文浏览量: 2
- PDF下载量: 899
- 被引次数: 0